Devices, methods, and kits for isolation and detection of analytes using microslit filters

Patent metadata

Field	Value
Publication number	US-11931739-B2
Application number	US-201816639471-A
Country	US
Kind code	B2
Filing date	Aug 16, 2018
Priority date	Aug 16, 2017
Publication date	Mar 19, 2024
Grant date	Mar 19, 2024

Abstract

Provided are methods, devices, and kits for the isolation and detection of one or more analytes of interest from a biological sample using microslit filter membranes. In various examples, the methods use capture particles and binding agents for specific recognition of one or more analytes of interest.

First claim

The invention claimed is:

1. A device comprising:
a microslit filter defining a plurality of openings;
wherein the microslit filter has a thickness from 50 nm to 25 μm;
a porosity from 1% to 75% and
wherein the openings are cubic prisms or trapezoids;
the openings have a width from 0.5 μm to 15 μm and a length from 5 μm to 100 μm; and
the openings have an aspect ratio (width:length) from 1:0.33 to 1:200.

2. The device of claim 1 , further comprising a first fluidic channel or chamber on a side of the microslit filter and a second fluidic channel or chamber on an opposite side of the microslit filter.

3. The device of claim 1 , wherein the microslit filter is 400 nm thick and has 17% porosity, wherein the openings are 9 μm in width and 50 μm in length, and wherein the openings have an aspect ratio of 1:5.5; or
wherein the microslit filter is 400 nm thick and has 17% porosity, wherein the openings are 8 μm in width and 50 μm in length, and wherein the openings have an aspect ratio of 1:6.25.

4. The device of claim 1 , further comprising at least two sorting membrane elements.

5. The device of claim 1 , further comprising a transducer for mechanical sonication, a heating element, and/or UV light source.

6. The device of claim 1 , wherein the microslit filter are functionalized to decrease adhesion of biofluid constituents; or
wherein the microslit filter and/or sorting membranes are functionalized to increase interactions between retained complexes and the microslit filter and/or sorting membranes.

7. The device of claim 1 , comprising a light source and a detector configured to record optical signals of an assay.

8. A method comprising:
forming analyte-affinity moiety-capture particle complexes with an analyte in a sample;
filtering the sample, thereby isolating at least a portion of the analyte-affinity moiety-capture particle complexes
wherein the filtering uses a microslit filter of claim 1 ; and
optionally, eluting the isolated analyte-affinity moiety-capture particle complexes and/or disassociating the isolated retained analyte-affinity moiety-capture particle complexes to liberate the analyte from the analyte-affinity moiety-capture particle.

9. The method of claim 8 , further comprising performing at least one analytical assay on the isolated analyte-affinity moiety-capture particle complexes and/or the liberated analyte.

10. The method of claim 8 , wherein the analyte is one of intact cells, sub cellular components, proteins, nucleic acids, carbohydrates, lipids, peptides, viruses, bacteria, fungi, drugs, metabolites, low molecular mass species, or a combination thereof.

11. The method of claim 8 , wherein the biofluid is one of cell lysates, venous whole blood, arterial whole blood, plasma, serum, sputum, urine, cerebrospinal fluid, or conditioned cell culture media.

12. The method of claim 8 , wherein the capture agent is an organic material, an inorganic material, or a combined organic-inorganic material.

13. The method of claim 8 , wherein the filtering includes one of gravity flow, hydrostatic pressure, pumping, vacuum, centrifugation, gas pressurization, or tangential flow and/or the filtering occurs at a pressure from 10 Pa to 1.0 kPa.

14. The method of claim 8 , wherein the capture particles have a diameter less than a width of the microslit filter.

15. The method of claim 8 , wherein the capture particles have a diameter greater than a width of the microslit filter.

16. A method comprising:
binding a first ligand on an analyte in a biofluid using a first binding agent, thereby forming an analyte-first binding agent complex;
adding capture particles to the biofluid, wherein the first binding agent is bound by the capture particles, thereby forming an analyte-first binding agent-capture particle complex;
filtering the biofluid having the analyte-first binding agent-capture particle complex with a microslit filter of claim 1 ; and
optionally, eluting or disassociating any of the analyte-first binding agent-capture particle complex that is retained by the microslit filter.

17. The method of claim 16 , further comprising performing at least one analytical assay on a analyte of the analyte-first binding agent-capture particle complex.

18. The method of claim 16 , wherein the analyte is one of intact cells, sub cellular components, proteins, nucleic acids, carbohydrates, lipids, peptides, viruses, bacteria, fungi, drugs, metabolites, or a combination thereof.

19. The method of claim 16 , wherein the biofluid is one of cell lysates, venous whole blood, arterial whole blood, plasma, serum, sputum, urine, cerebrospinal fluid, or conditioned cell culture media.

20. The method of claim 16 , wherein the first binding agent is one of monoclonal antibodies, polyclonal antibodies, fragments of monoclonal antibodies, fragments of polyclonal antibodies, DNA aptamers, RNA aptamers, peptides, modified peptide derivatives, lectins, bacteriophages, small molecules, or proteins, or a combination thereof; and
wherein the first binding agent is monovalent or multivalent.

21. The method of claim 16 , further comprising adding a second binding agent to the biofluid, wherein the second binding agent captures the first binding agent.

22. The method of claim 16 , wherein the capture agent is an organic material, an inorganic material, or a combined organic-inorganic material.

23. The method of claim 16 , wherein the filtering includes one of gravity flow, hydrostatic pressure, pumping, vacuum, centrifugation, gas pressurization, or tangential flow and/or the filtering occurs at a pressure from 10 Pa to 1.0 kPa.

24. The method of claim 16 , wherein the first binding agent includes two different types of the first binding agent, and wherein the capture particles include two different types of the capture particles.

25. The method of claim 16 , wherein the capture particles have a diameter less than a width of the microslit filter.

26. The method of claim 16 , wherein the capture particles have a diameter greater than a width of the microslit filter.

Assignees

• Simpore Inc
• Univ Rochester

Inventors

• Roussie James A
• Mcgrath James L
• Waugh Richard E
• Lucas Kilean S
• Miller Joshua J

Classifications

• B01L3/502753 Primary

  characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation · CPC title

• G01N1/4077

  by other techniques involving separation of suspended solids · CPC title

• G01N33/537

  with separation of immune complex from unbound antigen or antibody · CPC title

• B01L2300/0681

  Filter · CPC title

• G01N2001/4088

  filtration · CPC title